Show simple item record

dc.contributor.authorNanditha, Arun
dc.contributor.authorThomson, Hazel
dc.contributor.authorSusairaj, Priscilla
dc.contributor.authorSrivanichakorn, Weerachai
dc.contributor.authorOliver, Nick
dc.contributor.authorGodsland, Ian F.
dc.contributor.authorMajeed, Azeem
dc.contributor.authorDarzi, Ara
dc.contributor.authorSatheesh, Krishnamoorthy
dc.contributor.authorSimon, Mary
dc.contributor.authorRaghavan, Arun
dc.contributor.authorVinitha, Ramachandran
dc.contributor.authorSnehalatha, Chamukuttan
dc.contributor.authorWestgate, Kate
dc.contributor.authorBrage, Soren
dc.contributor.authorSharp, Stephen J.
dc.contributor.authorWareham, Nicholas J.
dc.contributor.authorJohnston, Desmond G.
dc.contributor.authorRamachandran, Ambady
dc.date.accessioned2021-01-08T17:22:08Z
dc.date.available2021-01-08T17:22:08Z
dc.date.issued2020-01-09
dc.date.submitted2019-06-26
dc.identifier.issn0012-186X
dc.identifier.others00125-019-05061-y
dc.identifier.other5061
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/315929
dc.description.abstractAbstract: Aims/hypothesis: This randomised controlled trial was performed in India and the UK in people with prediabetes to study whether mobile phone short message service (SMS) text messages can be used to motivate and educate people to follow lifestyle modifications, to prevent type 2 diabetes. Methods: The study was performed in people with prediabetes (n = 2062; control: n = 1031; intervention: n = 1031) defined by HbA1c ≥42 and ≤47 mmol/mol (≥6.0% and ≤6.4%). Participants were recruited from public and private sector organisations in India (men and women aged 35–55 years) and by the National Health Service (NHS) Health Checks programme in the UK (aged 40–74 years without pre-existing diabetes, cardiovascular disease or kidney disease). Allocation to the study groups was performed using a computer-generated sequence (1:1) in India and by stratified randomisation in permuted blocks in the UK. Investigators in both countries remained blinded throughout the study period. All participants received advice on a healthy lifestyle at baseline. The intervention group in addition received supportive text messages using mobile phone SMS messages 2–3 times per week. Participants were assessed at baseline and at 6, 12 and 24 months. The primary outcome was conversion to type 2 diabetes and secondary outcomes included anthropometry, biochemistry, dietary and physical activity changes, blood pressure and quality of life. Results: At the 2 year follow-up (n = 2062; control: n = 1031; intervention: n = 1031), in the intention-to-treat population the HR for development of type 2 diabetes calculated using a discrete-time proportional hazards model was 0.89 (95% CI 0.74, 1.07; p = 0.22). There were no significant differences in the secondary outcomes. Conclusions/interpretation: This trial in two countries with varied ethnic and cultural backgrounds showed no significant reduction in the progression to diabetes in 2 years by lifestyle modification using SMS messaging. Trial registration: The primary study was registered on www.ClinicalTrials.gov (India, NCT01570946; UK, NCT01795833). Funding: The study was funded jointly by the Indian Council for Medical Research and the UK Medical Research Council.
dc.languageen
dc.publisherSpringer Berlin Heidelberg
dc.rightsAttribution 4.0 International (CC BY 4.0)en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en
dc.subjectArticle
dc.subjectBehavioural change
dc.subjectDiabetes prevention
dc.subjectGlycosylated haemoglobin A1c
dc.subjectLifestyle modification
dc.subjectMobile technology
dc.subjectPrediabetes
dc.subjectScreening
dc.subjectShort message service
dc.titleA pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial
dc.typeArticle
dc.date.updated2021-01-08T17:22:08Z
prism.endingPage496
prism.issueIdentifier3
prism.publicationNameDiabetologia
prism.startingPage486
prism.volume63
dc.identifier.doi10.17863/CAM.63040
dcterms.dateAccepted2019-11-01
rioxxterms.versionofrecord10.1007/s00125-019-05061-y
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidRamachandran, Ambady [0000-0001-8313-0502]
dc.identifier.eissn1432-0428
pubs.funder-project-idIndian Council for Medical Research and Medical Research Council, UK (58/1/6/ICMR-MRC/2009-NCD-II, MR/J000183/1)


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International (CC BY 4.0)
Except where otherwise noted, this item's licence is described as Attribution 4.0 International (CC BY 4.0)